Literature DB >> 2305467

Noncompliance in organ transplant recipients.

R T Schweizer1, M Rovelli, D Palmeri, E Vossler, D Hull, S Bartus.   

Abstract

Noncompliance with medication and follow-up care was evaluated in 538 renal, 50 heart, and 13 liver transplant recipients. In a retrospective review of 260 kidney transplant recipients followed from three months posttransplant, the incidence of medication noncompliance was 18%. It was 15% in a prospective study of 196 kidney recipients from 1984 to 1987. Patients most likely to become noncompliant were young and in a lower socioeconomic group. There was no significant difference in the incidence of noncompliance with respect to cadaveric vs. living-related donor kidney source, or in male vs. female patients. There was a higher incidence of noncompliance in blacks and Hispanics, but that may have been due to a higher incidence of lower socioeconomic status in those groups. Noncompliance can occur many years posttransplant and was seen in heart and liver transplant recipients. In the retrospective study, 91% of kidney transplant recipients who were noncompliant with medications and follow-up care either lost their grafts or died. Noncompliant behavior was usually not predictable and was often without an identifiable reason. Efforts to increase compliance, such as better patient selection, more education, and simplified medical regimens may have reduced the incidence of noncompliance in recent patients.

Entities:  

Mesh:

Year:  1990        PMID: 2305467     DOI: 10.1097/00007890-199002000-00029

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  44 in total

Review 1.  Issues of adherence to immunosuppressant therapy after solid-organ transplantation.

Authors:  Marie A Chisholm
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Disparities in kidney transplant outcomes: a review.

Authors:  Elisa J Gordon; Daniela P Ladner; Juan Carlos Caicedo; John Franklin
Journal:  Semin Nephrol       Date:  2010-01       Impact factor: 5.299

Review 3.  Nonadherence in the Advanced Heart Failure Population.

Authors:  Jonathan Gandhi; Andrew McCue; Robert Cole
Journal:  Curr Heart Fail Rep       Date:  2016-04

4.  Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation.

Authors:  Ajay K Israni; Francis L Weng; Ye-Ying Cen; Marshall Joffe; Malek Kamoun; Harold I Feldman
Journal:  Clin Transplant       Date:  2010-10-26       Impact factor: 2.863

5.  Noncompliance in end-stage renal disease: A threat to quality of care and cost containment.

Authors:  A L Brickman; S E Yount
Journal:  J Clin Psychol Med Settings       Date:  1996-12

6.  A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients.

Authors:  Daniel Cukor; Nisha Ver Halen; Melissa Pencille; Fasika Tedla; Moro Salifu
Journal:  Nephron       Date:  2016-09-07       Impact factor: 2.847

7.  Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.

Authors:  Ileana A Ionita; Ken Ogasawara; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

8.  Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.

Authors:  T M Suszynski; K J Gillingham; M D Rizzari; T B Dunn; W D Payne; S Chinnakotla; E B Finger; D E R Sutherland; J S Najarian; T L Pruett; A J Matas; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

Review 9.  Minimization of steroids in kidney transplantation.

Authors:  Arthur J Matas
Journal:  Transpl Int       Date:  2008-07-24       Impact factor: 3.782

10.  Determinants of adherence to osteoporosis treatment in clinical practice.

Authors:  M Rossini; G Bianchi; O Di Munno; S Giannini; S Minisola; L Sinigaglia; S Adami
Journal:  Osteoporos Int       Date:  2006-03-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.